Dr. Thomas H. Meade, MD

Dr. Meade practices at EntireCare Rehab & Sports Medicine - West Flagstaff in Flagstaff, Arizona.

Dr. Meade's NPI, 1083674576, was assigned on March 27, 2006. Dr. Meade graduated from McGovern Medical School in 1993. Dr. Meade holds Texas license K9614.

Dr. Meade's primary practice is EntireCare Rehab & Sports Medicine - West Flagstaff, at 2000 S Thompson St, Flagstaff, AZ 86001. The practice phone is (717) 972-1100.

Dr. Meade's primary practice is EntireCare Rehab & Sports Medicine - West Flagstaff in Flagstaff, Arizona. Dr. Meade is also affiliated with Flagstaff Medical Center. The medical group on file is Northern Arizona Healthcare. Dmand AI also links Dr. Meade to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meade practices, 4 sites in all. Vendor and product names are available with a free account.

Clinical cardiac electrophysiology is Dr. Meade's primary specialty in the NPI Registry, under taxonomy code 207RC0001X. Dr. Meade is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Meade's licenses on file in 2 states: Texas and New Mexico.

Dmand AI lists atrial fibrillation and flutter, heart blockage, intermittent racing heartbeat (PSVT), pacemaker or defibrillator implantation, pacemaker replacement, sick sinus syndrome and ventricular tachycardia among the conditions Dr. Meade treats.

CMS data shows 2,690 Medicare services from Dr. Meade across 24 procedure codes in 2024, for 335 Medicare patients. Medicare paid $163,126 for them.

CMS counts 335 Medicare patients who saw Dr. Meade in 2024. The largest group is 75 to 84, with 143 patients. 75% of them have atrial fibrillation, and 75% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Meade's median patient age at 75, with 42% women.

In 2024, Dr. Meade wrote 994 Medicare Part D claims for 230 patients. 56% of them were for generic drugs. CMS names the drug for 893 of them, across 14 drugs with 11 or more claims each, at $476,848 in total drug cost. In 2023, CMS named 539 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Meade for performance year 2024, reported individually. Dr. Meade accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Meade as offering telehealth. CMS counts 23 procedures of pacemaker insertion or repair by Dr. Meade, more than 73% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Meade, published from 2012 to 2018. 2013 was the busiest year, with 4. The most frequent topics are Cross-Over Studies, Brachial Artery and Double-Blind Method. Dr. Meade has published most often in Exp Gerontol. Dr. Meade's most frequent co-authors are Mark Wayne English, MD and Iris Z. Jaffe, MD.

CMS Open Payments shows 70 general payments to Dr. Meade from 9 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 52% of the total. Abbott Laboratories paid the most, $3,322.

Dr. Meade graduated from McGovern Medical School in 1993.

Dr. Meade is in network with 21 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.